Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDCA7 pseudogene 1 (CDCA7P1) is a human pseudogene that shares sequence similarity with the protein-coding gene CDCA7 (cell division cycle associated 7), but it is annotated explicitly as a noncoding pseudogene and does not generate a functional protein[4]. As with most pseudogenes, CDCA7P1 is generally considered nonfunctional and is not involved in canonical biological roles, molecular functions, or disease processes, nor is it recognized as a drug target. By contrast, the related functional gene CDCA7 codes for a MYC-interacting protein involved in chromatin remodeling and epigenetic regulation, but the pseudogene CDCA7P1 itself lacks a protein product and is not studied as a receptor, enzyme, or other therapeutic target class[3][4]. If you are seeking druggability, biological function, or disease information, these pertain to CDCA7—not CDCA7P1. CDCA7 pseudogene 1 is a pseudogene, not a molecular target, and has no known biological or therapeutic role; therefore, it should not be classified as a target for drug interaction, mechanism-of-action, or disease biomarkers[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDCA7 pseudogene 1 (CDCA7P1).